معرفی
Associate Professor John O'Sullivan is a neurologist and researcher at the UQ Centre for Clinical Research, The University of Queensland, where he serves as co-director of the Neurodegeneration Clinical Research Group. He maintains strong clinical connections with the Royal Brisbane & Women's Hospital where he established and directs the Movement Disorders Clinical Service.
O'Sullivan completed his neurology training at the Royal Brisbane & Women's Hospital in 1995, followed by Fellowships in Movement Disorders at the Austin & Repatriation Medical Centre in Melbourne and the National Hospital for Neurology and Neurosurgery in London. He earned his Doctorate in Medicine from Melbourne University in 2000 for his research on surgery for Parkinson's disease.
His research focuses on Parkinson's disease, other movement disorders, and neurodegenerative conditions. O'Sullivan has established collaborations with researchers across Australia and internationally, particularly in Parkinson's disease, Huntington's disease, and Friedreich's ataxia. His work spans clinical management, neuroimaging, cognitive aspects of movement disorders, and therapeutic interventions.
Analysis of his recent publications shows a strong emphasis on cognitive aspects of Parkinson's disease, particularly mild cognitive impairment subtypes and dementia risk. His research also addresses anxiety disorders in Parkinson's patients, novel imaging techniques for movement disorders, and potential therapeutic approaches for neurodegenerative conditions. There's a clear translational focus, moving from basic mechanisms to clinical applications.
O'Sullivan has held significant leadership roles including past President of the Movement Disorders Society of Australia and New Zealand (MDSANZ) and service on the Council of the Australian and New Zealand Association of Neurologists (ANZAN). He previously chaired the MDSANZ Clinical Trials and Research Group and the ANZAN Scientific Program Committee.
He directs the comprehensive Movement Disorders Clinical Service at the Royal Brisbane & Women's Hospital, which includes specialized clinics for botulinum toxin treatment, Friedreich's ataxia, and coordinates the Huntington's disease multidisciplinary clinic. His research group actively participates in clinical trials and collaborative research projects focused on neurodegenerative disorders across Australia and internationally.
